pt-141
PT-141 (Bremelanotide) is an FDA-approved peptide for treating hypoactive sexual desire disorder. It works through melanocortin receptors in the brain to increase sexual desire, making it unique among sexual health treatments.
Lab Notes — Research Studies
01 Effect of bremelanotide on body weight of obese women
Bremelanotide reduced body weight and caloric intake in obese women in clinical trials, showing promise as a treatment for weight loss.
View Study ((Diabetes Obesity and Metabolism))02 Long-term safety and efficacy of bremelanotide for Hypoactive Sexual Desire Disorder
Study found that bremelanotide effectively improved sexual desire in premenopausal women with hypoactive sexual desire disorder over 52 weeks.
View Study ((George Washington University))03 Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder
In clinical trials, Bremelanotide significantly increased sexual desire and reduced distress in women with sexual dysfunction, showing a favorable safety profile.
View Study ((MacDonald Women's Hospital))Formula — Benefits & Dosage
⚗️ Effects
- FDA Approved: Clinically validated efficacy.
- Different Mechanism: Works when PDE5 inhibitors don't.
- Psychological Desire: Enhances wanting, not just function.
💉 Dosage & Administration
- Standard Dose: 1.75mg subcutaneously as needed.
- Timing: Administered 45 minutes before sexual activity.
- Frequency: Not more than once in 24 hours.
⚠️ Side Effects
- Nausea: Very common, can be significant.
- Flushing: Facial redness and warmth.
- Blood Pressure: Transient increase possible.
- Headache: Occasionally reported.
📦 Availability & Sourcing
- FDA Approved: Available as Vyleesi by prescription.
- Research Chemical: Also available from peptide suppliers.
- Higher Cost: Branded version is expensive.
Reaction Log — User Experiences
Users report significant increases in libido and sexual desire. Effects work differently than PDE5 inhibitors - targets desire rather than mechanics. Nausea common but manageable.
Synthesis — Related Compounds
⚠️ IMPORTANT DISCLAIMER
This information is for educational and research purposes only. pt-141 may not be approved for human use. Always consult a qualified healthcare professional before using any supplements or research compounds. We do not guarantee accuracy or completeness of information presented.